The F.D.A. seemed poised to rescind approval of Makena, after studies over time indicated the treatment did not halt early childbirth for many women.
This post first appeared in The New York Times – Business. Read the original article.Preterm Birth Drug Withdrawn After 12 Years
The New York Times – Business:
Written by
in
